Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/1585"
| Predicate | Value (sorted: none) |
|---|---|
| rdf:type | |
| rdf:type | |
| rdfs:label | |
| ?:Evidence_type | |
| ?:Evidence_object_dose | |
| ?:Evidence_precip_dose | |
| ?:Evidence_value |
"1.86"
|
| dc:creator | |
| dc:date |
"05/30/2012 14:18:21"
|
| ?:content |
"NOTE: The object_dose given is the oral dose of imipramine. 0.0125g imipramine was given in an iv dose in another part of the study. The AUC_i/AUC value given is for the oral imipramine/cimetidine phase and is calculated from the total AUC values in Table 1.
route of administration: oral (both), iv (imipramine)
study duration: 4 days
population: 6 healthy volunteers
tested for known CYP450 polymorphisms?
NO
ages: 24-35"
|
| rdfs:seeAlso |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ cimetidine_increases_auc_imipramine, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1742 }